SB-242084

From WikiMD's Wellness Encyclopedia

SB242084.png

Selective 5-HT2C receptor antagonist


{{Infobox drug | image = | width = | alt = | caption = | IUPAC name = 6-Chloro-5-methyl-1-[[2-(2-methylpyridin-3-yloxy)ethyl]oxy]-2,3-dihydro-1H-indole | CAS number = 181632-25-9 | ATC prefix = | ATC suffix = | PubChem = 5311277 | ChemSpiderID = 4470904 | UNII = 0T493YFU8O | KEGG = D05966 | ChEMBL = 123187 | C=17 | H=20 | Cl=1 | N=1 | O=2 | molecular weight = 305.8 | smiles = CC1=CC=NC(=C1)OCCOC2=CC3=C(C=C2Cl)N(CC3)C | StdInChI = 1S/C17H20ClNO2/c1-11-4-5-19-17(8-11)21-9-10-20-14-6-7-15-13(12(14)2)3-16(18)22-15/h3-8H,9-10H2,1-2H3 | StdInChIKey = QXQXKJZQJXKJQF-UHFFFAOYSA-N }}

SB-242084 is a selective 5-HT2C receptor antagonist. It is commonly used in scientific research to investigate the role of the serotonin 2C receptor in various physiological and pathological processes.

Pharmacology[edit | edit source]

SB-242084 has been shown to have high affinity and selectivity for the 5-HT2C receptor, with significantly lower affinity for other serotonin receptors such as 5-HT2A and 5-HT2B. This selectivity makes it a valuable tool in research for distinguishing the specific effects mediated by the 5-HT2C receptor.

Research Applications[edit | edit source]

SB-242084 is used in a variety of research contexts, including studies on anxiety, depression, schizophrenia, and obesity. By blocking the 5-HT2C receptor, researchers can better understand the receptor's role in these conditions and potentially develop new therapeutic strategies.

Anxiety and Depression[edit | edit source]

Studies have shown that SB-242084 can produce anxiolytic and antidepressant-like effects in animal models. This suggests that the 5-HT2C receptor may play a role in the regulation of mood and anxiety, making it a potential target for new treatments.

Schizophrenia[edit | edit source]

Research indicates that the 5-HT2C receptor may be involved in the pathophysiology of schizophrenia. SB-242084 is used to explore this connection and to evaluate the potential of 5-HT2C receptor antagonists as antipsychotic agents.

Obesity[edit | edit source]

The 5-HT2C receptor is also implicated in the regulation of appetite and body weight. SB-242084 is used to study its role in these processes, with the aim of developing new treatments for obesity and related metabolic disorders.

Chemical Properties[edit | edit source]

SB-242084 has the chemical formula C17H20ClNO2 and a molecular weight of 305.8 g/mol. Its structure includes a chloroindole moiety and a pyridine ring, which contribute to its high affinity and selectivity for the 5-HT2C receptor.

See Also[edit | edit source]

References[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD